Literature DB >> 11788535

Obesity.

Corri Wolf1, Michael Tanner.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11788535      PMCID： PMC1071649          DOI： 10.1136/ewjm.176.1.23

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  18 in total

1.  Recent advances in basic obesity research.

Authors:  J A Yanovski; S Z Yanovski
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

2.  Self-reported weight and height.

Authors:  M L Rowland
Journal:  Am J Clin Nutr       Date:  1990-12       Impact factor: 7.045

3.  Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.

Authors:  C Hanotin; F Thomas; S P Jones; E Leutenegger; P Drouin
Journal:  Int J Obes Relat Metab Disord       Date:  1998-01

4.  Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.

Authors:  J O Hill; J Hauptman; J W Anderson; K Fujioka; P M O'Neil; D K Smith; J H Zavoral; L J Aronne
Journal:  Am J Clin Nutr       Date:  1999-06       Impact factor: 7.045

Review 5.  Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care.

Authors:  J D Douketis; J W Feightner; J Attia; W F Feldman
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

6.  The effect of age on the association between body-mass index and mortality.

Authors:  J Stevens; J Cai; E R Pamuk; D F Williamson; M J Thun; J L Wood
Journal:  N Engl J Med       Date:  1998-01-01       Impact factor: 91.245

Review 7.  Surgery for obesity.

Authors:  F L Greenway
Journal:  Endocrinol Metab Clin North Am       Date:  1996-12       Impact factor: 4.741

8.  Treatment with orlistat reduces cardiovascular risk in obese patients.

Authors:  J H Zavoral
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

9.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Authors:  L Sjöström; A Rissanen; T Andersen; M Boldrin; A Golay; H P Koppeschaar; M Krempf
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

10.  A double-blind randomized placebo-controlled trial of sibutramine.

Authors:  G A Bray; D H Ryan; D Gordon; S Heidingsfelder; F Cerise; K Wilson
Journal:  Obes Res       Date:  1996-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.